Neuropsychiatric Symptoms
9
2
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (9)
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
Augmented Reality-Based Aromatherapy Education for Older Adults With Early-Stage Dementia in Taiwan
The Pain Reduction Using Immersive Virtual Reality During Wound Care Evaluation Study at Maimonides (PRISM) - Pilot Study
Treatment for Social Cognition Disorders (T-ScEmo) in Patients With Acquired Brain Injury and Comorbid Neuropsychiatric Problems
Validation of the MBI-C Scale in French
Different Doses of Dexmedetomidine Combined With Esketamine in Women Undergoing Cesarean Delivery
Electro-acupuncture for Long Covid Neuropsychiatric Symptoms
Exploring Use of Companion Robot Pets for Older Adults in Care Homes